Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Expert Rev Mol Diagn. 2016 Dec;16(12):1337–1351. doi: 10.1080/14737159.2016.1259069

Table 1.

Molecular characteristics of type 1 and 2 ovarian cancer neoplasms.

Histology Molecular characteristic
Type 2 High grade serous TP53 mutation
BRCA1/2
HRD
WT1
KRAS mutation
PIK3CA amplification
High grade endometrioid PIK3CA mutation
TP53 mutation
WT1
Type 1 Low grade serous KRAS mutation
BRAF mutation
ER+/PR+
EGFR amplification
PIK3CA amplification/mutation
PTEN mutation
Low grade endometrioid CTTNB1 mutation
PTEN mutation
PIK3CA mutation
ARID1A mutation
BRAF mutation
Clear cell IL6/JAK2/STAT3 pathway
ARID1A mutation
PTEN mutation or LOH
PIK3CA amplification/mutation
EGFR amplification /mutation
Mucinous KRAS mutation
BRAF mutation
HER2 amplification